{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:28:32Z","timestamp":1792056512044,"version":"4.4.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Alydia Health Inc and Organon & Co"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To assess the real-world effectiveness and safety of a U.S. Food and Drug Administration (FDA)\u2013cleared intrauterine vacuum-induced-hemorrhage control device for postpartum hemorrhage (PPH) management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      Sixteen centers in the United States participated in this observational, postmarket registry medical record review (October 2020 through March 2022). The primary effectiveness outcome was\n                      <jats:italic toggle=\"yes\">treatment success<\/jats:italic>\n                      , defined as bleeding control after insertion with no treatment escalation or bleeding recurrence. Additional outcomes included blood loss, time to device insertion, indwelling time, bleeding recurrence, and time to bleeding control. Treatment success and severe maternal morbidity measures (transfusion of 4 or more units of red blood cell, intensive care unit admission, and hysterectomy) were evaluated by blood loss before insertion. To assess safety, serious adverse events (SAEs) and adverse device effects were collected. All outcomes were summarized by mode of delivery; treatment success was summarized by bleeding cause (all causes, any atony, isolated atony, nonatony).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>In total, 800 individuals (530 vaginal births, 270 cesarean births) were treated with the device; 94.3% had uterine atony (alone or in combination with other causes). Median total blood loss at device insertion was 1,050 mL in vaginal births and 1,600 mL in cesarean births. Across all bleeding causes, the treatment success rate was 92.5% for vaginal births and was 83.7% for cesarean births (95.8% [n=307] and 88.2% [n=220], respectively, in isolated atony). Median indwelling time was 3.1 hours and 4.6 hours, respectively. In vaginal births, 14 SAEs were reported among 13 individuals (2.5%). In cesarean births, 22 SAEs were reported among 21 individuals (7.8%). Three (0.4%) SAEs were deemed possibly related to the device or procedure. No uterine perforations or deaths were reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>For both vaginal and cesarean births in real-world settings, rapid and effective bleeding control was achieved with an FDA-cleared intrauterine vacuum-induced hemorrhage-control device. The safety profile was consistent with that observed in the registrational trial (NCT02883673), and SAEs or adverse device effects were of the nature and severity expected in the setting of PPH. This device is an important new tool for managing a life-threatening condition, and timely utilization may help to improve obstetric hemorrhage outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, NCT04995887.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000005366","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T19:15:09Z","timestamp":1694718909000},"page":"1006-1016","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":30,"title":["Real-World Utilization of an Intrauterine, Vacuum-Induced, Hemorrhage-Control Device"],"prefix":"10.1097","volume":"142","author":[{"given":"Dena","family":"Goffman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara M.","family":"Rood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Biggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Heilman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeve","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"De Four Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela C.","family":"Smid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn D.","family":"Wine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia I.","family":"Carney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyagriv N.","family":"Simhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/AOG.0b013e31826d60c5","article-title":"Severe maternal morbidity among delivery and postpartum hospitalizations in the United States","volume":"120","author":"Callaghan","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"e2244077","DOI":"10.1001\/jamanetworkopen.2022.44077","article-title":"Findings from severe maternal morbidity surveillance and review in Maryland","volume":"5","author":"Wolfson","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R6-20260916","first-page":"247","article-title":"A national update on rates of postpartum haemorrhage and related interventions","volume":"18","author":"Ahmadzia","year":"2020","journal-title":"Blood Transfus"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/AOG.0000000000004972","article-title":"Postpartum hemorrhage trends and outcomes in the United States, 2000-2019","volume":"141","author":"Corbetta-Rastelli","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/AOG.0000000000000869","article-title":"National partnership for maternal safety: consensus bundle on obstetric hemorrhage","volume":"121","author":"Main","year":"2015","journal-title":"Anesth Analg"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1097\/AOG.0000000000002351","article-title":"Postpartum hemorrhage. Practice Bulletin No. 183. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"100739","DOI":"10.1016\/j.ajogmf.2022.100739","article-title":"Traditional uterine tamponade and vacuum-induced uterine tamponade devices in obstetrical hemorrhage management","volume":"5","author":"Phillips","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"293.e1","DOI":"10.1016\/j.ajog.2019.11.1287","article-title":"Uterine balloon tamponade for the treatment of postpartum hemorrhage: a systematic review and meta-analysis","volume":"222","author":"Suarez","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/17434440.2021.1962288","article-title":"Profile of the Jada\u00ae System: the vacuum-induced hemorrhage control device for treating abnormal postpartum uterine bleeding and postpartum hemorrhage","volume":"18","author":"D'Alton","year":"2021","journal-title":"Expert Rev Med Devices"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/AOG.0000000000004138","article-title":"Intrauterine vacuum-induced hemorrhage-control device for rapid treatment of postpartum hemorrhage","volume":"136","author":"D'Alton","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"185.e1","DOI":"10.1016\/j.ajog.2018.04.052","article-title":"Postpartum hemorrhage outcomes and race","volume":"219","author":"Gyamfi-Bannerman","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R20-20260916","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/1471-0528.17440","article-title":"Women and partners' experience of major postpartum haemorrhage: a qualitative study","volume":"130","author":"Rosvig","year":"2023","journal-title":"BJOG"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"76.e1","DOI":"10.1016\/j.ajog.2015.02.023","article-title":"Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines","volume":"213","author":"Dahlke","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"e2226531","DOI":"10.1001\/jamanetworkopen.2022.26531","article-title":"Comparison of pregnancy and birth outcomes before vs during the COVID-19 pandemic","volume":"5","author":"Molina","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R23-20260916","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/jwh.2022.0214","article-title":"Hospital characteristics and other factors associated with the risk of postpartum hemorrhage in the United States","volume":"32","author":"Shahin","year":"2023","journal-title":"J Womens Health (Larchmt)"},{"key":"R24-20260916","first-page":"e13591","article-title":"Quantification of blood loss improves detection of postpartum hemorrhage and accuracy of postpartum hemorrhage rates: a retrospective cohort study","volume":"13","author":"Blosser","year":"2021","journal-title":"Cureus"}],"updated-by":[{"DOI":"10.1097\/aog.0000000000005688","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000}}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:05:07Z","timestamp":1789556707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005366","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,13]]},"assertion":[{"value":"2023-05-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}